A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
Cancer stem cells (CSCs) represent a distinct subpopulation within tumours, characterised by their capacity for self‐renewal and differentiation. These cells are pivotal in driving tumour growth, ...
New radioimmunotherapy approach eliminates cancer stem cells in preclinical models of ovarian cancer
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
1don MSN
Small number of 'highly plastic' cancer cells drive disease progression and treatment resistance
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...
Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after treatment. Traditional treatments like chemotherapy, radiation, and even ...
Schematic showing IL-6-induced STAT3-to-PI3K signaling switch in colorectal cancer stem cells, driving ZEB1-dependent PD-L1 expression and immune evasion. A landmark study published in Science ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback